Aptose Biosciences Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Subsequent Event (Details Textual) $ / shares in Units, $ in Millions	Jan. 13, 2025 Days $ / shares	Aug. 02, 2024 USD ($)	Jul. 16, 2024 $ / shares
Subsequent Event [Member]
Decrease in anticipated payroll costs \| $		$ 1.2
Common Shares [Member] \| Forecast [Member]
Common stock, par value	$ 1
Description of subsequent event	The Company has been given 180 calendar days, or until January 13, 2025, to regain compliance with the Minimum Bid Price Requirement. If at any time before January 13, 2025, the bid price of the Company’s Common Shares closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Staff will provide written confirmation that the Company has achieved compliance. If the Company does not regain compliance with the Minimum Bid Price Requirement by January 13, 2025, the Company may be afforded a second 180 calendar day period to regain compliance.
Consecutive business days \| Days	10
Minimum [Member] \| Subsequent Event [Member]
Common stock, par value			$ 1